![Scott Platshon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Scott Platshon
Direttore operativo presso
PANACEA ACQUISITION CORP. II
Profilo
Mr. Scott B. Platshon is a Chief Business Officer & Executive Vice President at Zymeworks, Inc., a Chief Operating Officer at Panacea Acquisition Corp.
II and a Partner at Ecor1 Capital LLC /Venture Capital/.
He is on the Board of Directors at Theravance Biopharma, Inc., Ajax Therapeutics, Inc. and Kumquat Biosciences, Inc. Mr. Platshon was previously employed as an Independent Director by Silverback Therapeutics, Inc., a Chief Operating Officer by Panacea Acquisition Corp., and a Partner by EcoR1 Capital, LLC.
He also served on the board at Terremoto Biosciences, Inc. He received his undergraduate degree from Stanford University.
Posizioni attive di Scott Platshon
| Società | Posizione | Inizio |
|---|---|---|
| PANACEA ACQUISITION CORP. II | Direttore operativo | 01/01/2021 |
| ZYMEWORKS INC. | Corporate Officer/Principal | 09/04/2026 |
| THERAVANCE BIOPHARMA | Direttore/Membro del Consiglio | 23/09/2026 |
Ajax Therapeutics, Inc.
 Ajax Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in R&D, clinical trial and manufactures hematologic cancer therapeutics | Direttore/Membro del Consiglio | 01/05/2021 |
Kumquat Biosciences, Inc.
 Kumquat Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapeutics | Direttore/Membro del Consiglio | 01/02/2021 |
Precedenti posizioni note di Scott Platshon
| Società | Posizione | Fine |
|---|---|---|
EcoR1 Capital, LLC
 EcoR1 Capital, LLC Investment ManagersFinance EcoR1 invests (long and short) in securities, consisting principally, but not solely, of equity and equity-related securities that are issued by biotechnology companies globally. | Analyst-Equity | 01/03/2026 |
Terremoto Biosciences, Inc.
 Terremoto Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company which develops drugs for oncology and genetic diseases | Direttore/Membro del Consiglio | 01/12/2024 |
| ARS PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | - |
Panacea Acquisition Corp.
 Panacea Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Direttore operativo | - |
Formazione di Scott Platshon
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
90
Relazioni di 1° grado
10
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EcoR1 Capital, LLC
EcoR1 Capital, LLC Investment ManagersFinance EcoR1 invests (long and short) in securities, consisting principally, but not solely, of equity and equity-related securities that are issued by biotechnology companies globally. | Finance |
Theravance Biopharma, Inc.
 Theravance Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of human therapeutics products for respiratory diseases | Health Technology |
Silverback Therapeutics, Inc.
 Silverback Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Ajax Therapeutics, Inc.
Ajax Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in R&D, clinical trial and manufactures hematologic cancer therapeutics | Commercial Services |
Kumquat Biosciences, Inc.
Kumquat Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapeutics | Health Technology |
Panacea Acquisition Corp.
Panacea Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Panacea Acquisition Corp. II
 Panacea Acquisition Corp. II Financial ConglomeratesFinance Operates as a blank check company | Finance |
Terremoto Biosciences, Inc.
Terremoto Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company which develops drugs for oncology and genetic diseases | Health Technology |
Zymeworks, Inc.
 Zymeworks, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
